Research ExplorerPublicationsDigital rheumatology in the era of COVID-19: results of a na...

Digital rheumatology in the era of COVID-19: results of a national patient and physician survey

Standard

Digital rheumatology in the era of COVID-19: results of a national patient and physician survey. / Kernder, Anna; Morf, Harriet; Klemm, Philipp; Vossen, Diana; Haase, Isabell; Mucke, Johanna; Meyer, Marco; Kleyer, Arnd; Sewerin, Philipp; Bendzuck, Gerlinde; Eis, Sabine; Knitza, Johannes; Krusche, Martin.

In: RMD OPEN, Vol. 7, No. 1, e001548, 02.2021.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Kernder, A, Morf, H, Klemm, P, Vossen, D, Haase, I, Mucke, J, Meyer, M, Kleyer, A, Sewerin, P, Bendzuck, G, Eis, S, Knitza, J & Krusche, M 2021, 'Digital rheumatology in the era of COVID-19: results of a national patient and physician survey', RMD OPEN, vol. 7, no. 1, e001548. https://doi.org/10.1136/rmdopen-2020-001548

APA

Kernder, A., Morf, H., Klemm, P., Vossen, D., Haase, I., Mucke, J., Meyer, M., Kleyer, A., Sewerin, P., Bendzuck, G., Eis, S., Knitza, J., & Krusche, M. (2021). Digital rheumatology in the era of COVID-19: results of a national patient and physician survey. RMD OPEN, 7(1), [e001548]. https://doi.org/10.1136/rmdopen-2020-001548

Vancouver

Kernder A, Morf H, Klemm P, Vossen D, Haase I, Mucke J et al. Digital rheumatology in the era of COVID-19: results of a national patient and physician survey. RMD OPEN. 2021 Feb;7(1). e001548. https://doi.org/10.1136/rmdopen-2020-001548

Bibtex

@article{694e56eca38b4f049ee27c608cf646a5,
title = "Digital rheumatology in the era of COVID-19: results of a national patient and physician survey",
abstract = "OBJECTIVE: To analyse the impact of the COVID-19 pandemic on rheumatic patients' and rheumatologists' usage, preferences and perception of digital health applications (DHAs).METHODS: A web-based national survey was developed by the Working Group Young Rheumatology of the German Society for Rheumatology and the German League against Rheumatism. The prospective survey was distributed via social media (Twitter, Instagram and Facebook), QR code and email. Descriptive statistics were calculated, and regression analyses were performed to show correlations.RESULTS: We analysed the responses of 299 patients and 129 rheumatologists. Most patients (74%) and rheumatologists (76%) believed that DHAs are useful in the management of rheumatic and musculoskeletal diseases (RMDs) and felt confident in their own usage thereof (90%; 86%). 38% of patients and 71% of rheumatologists reported that their attitude had changed positively towards DHAs and that their usage had increased due to COVID-19 (29%; 48%). The majority in both groups agreed on implementing virtual visits for follow-up appointments in stable disease conditions. The most reported advantages of DHAs were usage independent of time and place (76.6%; 77.5%). The main barriers were a lack of information on suitable, available DHAs (58.5%; 41.9%), poor usability (42.1% of patients) and a lack of evidence supporting the effectiveness of DHAs (23.2% of rheumatologists). Only a minority (<10% in both groups) believed that digitalisation has a negative impact on the patient-doctor relationship.CONCLUSION: The COVID-19 pandemic instigated an increase in patients' and rheumatologists' acceptance and usage of DHAs, possibly introducing a permanent paradigm shift in the management of RMDs.",
keywords = "Adolescent, Adult, Aged, Aged, 80 and over, COVID-19, Female, Health Knowledge, Attitudes, Practice, Humans, Male, Middle Aged, Musculoskeletal Diseases/therapy, Patient Acceptance of Health Care/statistics & numerical data, Prospective Studies, Rheumatologists/statistics & numerical data, Surveys and Questionnaires, Telemedicine, Young Adult",
author = "Anna Kernder and Harriet Morf and Philipp Klemm and Diana Vossen and Isabell Haase and Johanna Mucke and Marco Meyer and Arnd Kleyer and Philipp Sewerin and Gerlinde Bendzuck and Sabine Eis and Johannes Knitza and Martin Krusche",
note = "{\textcopyright} Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.",
year = "2021",
month = feb,
doi = "10.1136/rmdopen-2020-001548",
language = "English",
volume = "7",
journal = "RMD OPEN",
issn = "2056-5933",
publisher = "BMJ PUBLISHING GROUP",
number = "1",

}

RIS

TY - JOUR

T1 - Digital rheumatology in the era of COVID-19: results of a national patient and physician survey

AU - Kernder, Anna

AU - Morf, Harriet

AU - Klemm, Philipp

AU - Vossen, Diana

AU - Haase, Isabell

AU - Mucke, Johanna

AU - Meyer, Marco

AU - Kleyer, Arnd

AU - Sewerin, Philipp

AU - Bendzuck, Gerlinde

AU - Eis, Sabine

AU - Knitza, Johannes

AU - Krusche, Martin

N1 - © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

PY - 2021/2

Y1 - 2021/2

N2 - OBJECTIVE: To analyse the impact of the COVID-19 pandemic on rheumatic patients' and rheumatologists' usage, preferences and perception of digital health applications (DHAs).METHODS: A web-based national survey was developed by the Working Group Young Rheumatology of the German Society for Rheumatology and the German League against Rheumatism. The prospective survey was distributed via social media (Twitter, Instagram and Facebook), QR code and email. Descriptive statistics were calculated, and regression analyses were performed to show correlations.RESULTS: We analysed the responses of 299 patients and 129 rheumatologists. Most patients (74%) and rheumatologists (76%) believed that DHAs are useful in the management of rheumatic and musculoskeletal diseases (RMDs) and felt confident in their own usage thereof (90%; 86%). 38% of patients and 71% of rheumatologists reported that their attitude had changed positively towards DHAs and that their usage had increased due to COVID-19 (29%; 48%). The majority in both groups agreed on implementing virtual visits for follow-up appointments in stable disease conditions. The most reported advantages of DHAs were usage independent of time and place (76.6%; 77.5%). The main barriers were a lack of information on suitable, available DHAs (58.5%; 41.9%), poor usability (42.1% of patients) and a lack of evidence supporting the effectiveness of DHAs (23.2% of rheumatologists). Only a minority (<10% in both groups) believed that digitalisation has a negative impact on the patient-doctor relationship.CONCLUSION: The COVID-19 pandemic instigated an increase in patients' and rheumatologists' acceptance and usage of DHAs, possibly introducing a permanent paradigm shift in the management of RMDs.

AB - OBJECTIVE: To analyse the impact of the COVID-19 pandemic on rheumatic patients' and rheumatologists' usage, preferences and perception of digital health applications (DHAs).METHODS: A web-based national survey was developed by the Working Group Young Rheumatology of the German Society for Rheumatology and the German League against Rheumatism. The prospective survey was distributed via social media (Twitter, Instagram and Facebook), QR code and email. Descriptive statistics were calculated, and regression analyses were performed to show correlations.RESULTS: We analysed the responses of 299 patients and 129 rheumatologists. Most patients (74%) and rheumatologists (76%) believed that DHAs are useful in the management of rheumatic and musculoskeletal diseases (RMDs) and felt confident in their own usage thereof (90%; 86%). 38% of patients and 71% of rheumatologists reported that their attitude had changed positively towards DHAs and that their usage had increased due to COVID-19 (29%; 48%). The majority in both groups agreed on implementing virtual visits for follow-up appointments in stable disease conditions. The most reported advantages of DHAs were usage independent of time and place (76.6%; 77.5%). The main barriers were a lack of information on suitable, available DHAs (58.5%; 41.9%), poor usability (42.1% of patients) and a lack of evidence supporting the effectiveness of DHAs (23.2% of rheumatologists). Only a minority (<10% in both groups) believed that digitalisation has a negative impact on the patient-doctor relationship.CONCLUSION: The COVID-19 pandemic instigated an increase in patients' and rheumatologists' acceptance and usage of DHAs, possibly introducing a permanent paradigm shift in the management of RMDs.

KW - Adolescent

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - COVID-19

KW - Female

KW - Health Knowledge, Attitudes, Practice

KW - Humans

KW - Male

KW - Middle Aged

KW - Musculoskeletal Diseases/therapy

KW - Patient Acceptance of Health Care/statistics & numerical data

KW - Prospective Studies

KW - Rheumatologists/statistics & numerical data

KW - Surveys and Questionnaires

KW - Telemedicine

KW - Young Adult

U2 - 10.1136/rmdopen-2020-001548

DO - 10.1136/rmdopen-2020-001548

M3 - SCORING: Journal article

C2 - 33622673

VL - 7

JO - RMD OPEN

JF - RMD OPEN

SN - 2056-5933

IS - 1

M1 - e001548

ER -